Portfolio company
AUGURIX SA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and manufactures rapid point-of-care diagnostic tests for gastrointestinal diseases, specifically celiac disease, for patients and healthcare institutions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alba Therapeutics Corp
This biopharmaceutical company develops oral peptide therapeutics to treat autoimmune and inflammatory conditions, such as celiac disease, for patients with gastrointestinal disorders.
NOWDiagnostics
This company develops and manufactures rapid over-the-counter and point-of-care diagnostic tests for consumers and healthcare professionals.
Allergios
This company develops a cell-based diagnostic platform for clinicians to perform precise in vitro allergy tests using blood samples and automated visual analysis.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
Kenota Health
This company develops point-of-care diagnostic systems that provide rapid allergy testing results for physicians and their patients.
Abionic
This company develops nanofluidic point-of-care diagnostic platforms and blood tests for healthcare professionals to enable rapid detection of sepsis, allergies and iron deficiencies.
Avexegen
This biopharmaceutical company develops peptide therapies to treat gastrointestinal disorders and restore gut health for patients with inflammatory conditions.
Slive
This company develops point-of-care diagnostic tests for clinicians to improve the speed and accuracy of medical screenings.
